ALPHAMAB-B (09966.HK) Stock Community - Hot Topic Discussions - Longbridge

Quote List Quote List

Event Tracking

Dec18

KN003 Receives FDA Breakthrough Therapy Designation

04:09

Dec11

02:26

Nov26

Kangning Junrui Pharmaceutical-B Resolves to Repurchase Up to HKD 30 Million Ordinary Shares

06:15

Nov17

Knightsbridge Biopharma B Repurchased 350,000 Shares for HKD 3.4198 million

12:48

Nov11

XY Securities Gives 'Outperform' Rating to Conjecta-B

06:22

Nov10

CStone Pharmaceuticals-B Plans Open Market Share Repurchase

00:18

Schedules & Filings

Schedules

Filings

Aug28

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 174.82 M, Net Income 11.81 M, EPS 0.0109

Mar25

Earning Release(CST)

FY2024 Q4 Earning Release (HKD) Revenue 248.16 M, Net Income 112.36 M, EPS 0.1139

Aug15

Earning Release(CST)

FY2024 Q2 Earning Release (HKD) Revenue 93.25 M, Net Income -24.12 M, EPS -0.0268

View More

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change

View More